1. Home
  2. DH vs ALDX Comparison

DH vs ALDX Comparison

Compare DH & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DH
  • ALDX
  • Stock Information
  • Founded
  • DH 2011
  • ALDX 2004
  • Country
  • DH United States
  • ALDX United States
  • Employees
  • DH N/A
  • ALDX N/A
  • Industry
  • DH Computer Software: Prepackaged Software
  • ALDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • DH Technology
  • ALDX Health Care
  • Exchange
  • DH Nasdaq
  • ALDX Nasdaq
  • Market Cap
  • DH 310.5M
  • ALDX 304.9M
  • IPO Year
  • DH 2021
  • ALDX 2014
  • Fundamental
  • Price
  • DH $2.90
  • ALDX $6.46
  • Analyst Decision
  • DH Hold
  • ALDX Strong Buy
  • Analyst Count
  • DH 11
  • ALDX 2
  • Target Price
  • DH $5.35
  • ALDX $10.00
  • AVG Volume (30 Days)
  • DH 1.3M
  • ALDX 666.8K
  • Earning Date
  • DH 05-06-2025
  • ALDX 05-01-2025
  • Dividend Yield
  • DH N/A
  • ALDX N/A
  • EPS Growth
  • DH N/A
  • ALDX N/A
  • EPS
  • DH N/A
  • ALDX N/A
  • Revenue
  • DH $252,202,000.00
  • ALDX N/A
  • Revenue This Year
  • DH N/A
  • ALDX N/A
  • Revenue Next Year
  • DH $3.23
  • ALDX N/A
  • P/E Ratio
  • DH N/A
  • ALDX N/A
  • Revenue Growth
  • DH 0.31
  • ALDX N/A
  • 52 Week Low
  • DH $2.55
  • ALDX $2.75
  • 52 Week High
  • DH $8.35
  • ALDX $7.20
  • Technical
  • Relative Strength Index (RSI)
  • DH 31.44
  • ALDX 53.63
  • Support Level
  • DH $2.56
  • ALDX $6.22
  • Resistance Level
  • DH $2.90
  • ALDX $6.87
  • Average True Range (ATR)
  • DH 0.19
  • ALDX 0.46
  • MACD
  • DH 0.03
  • ALDX -0.03
  • Stochastic Oscillator
  • DH 53.54
  • ALDX 60.51

About DH Definitive Healthcare Corp.

Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.

Share on Social Networks: